位置:首页 > 蛋白库 > S38A1_MOUSE
S38A1_MOUSE
ID   S38A1_MOUSE             Reviewed;         485 AA.
AC   Q8K2P7; Q3TNM1; Q3TQ53; Q6NXZ2; Q8BHI3; Q8BXE2; Q99PR1;
DT   13-NOV-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   03-AUG-2022, entry version 139.
DE   RecName: Full=Sodium-coupled neutral amino acid transporter 1;
DE   AltName: Full=Amino acid transporter A1;
DE   AltName: Full=MNat2;
DE   AltName: Full=N-system amino acid transporter 2;
DE   AltName: Full=Solute carrier family 38 member 1;
DE   AltName: Full=System A amino acid transporter 1;
DE   AltName: Full=System N amino acid transporter 1;
GN   Name=Slc38a1; Synonyms=Nat2, Snat1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, BIOPHYSICOCHEMICAL
RP   PROPERTIES, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=11325958; DOI=10.1074/jbc.m009003200;
RA   Gu S., Roderick H.L., Camacho P., Jiang J.X.;
RT   "Characterization of an N-system amino acid transporter expressed in retina
RT   and its involvement in glutamine transport.";
RL   J. Biol. Chem. 276:24137-24144(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   STRAIN=C57BL/6J;
RC   TISSUE=Cerebellum, Diencephalon, Embryo, Embryonic head,
RC   Embryonic stem cell, and Head;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   STRAIN=CD-1, and FVB/N-3; TISSUE=Mammary tumor, and Neural stem cell;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   INDUCTION BY BDNF.
RX   PubMed=17179157; DOI=10.1074/jbc.m608548200;
RA   Burkhalter J., Fiumelli H., Erickson J.D., Martin J.-L.;
RT   "A critical role for system A amino acid transport in the regulation of
RT   dendritic development by brain-derived neurotrophic factor (BDNF).";
RL   J. Biol. Chem. 282:5152-5159(2007).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-6 AND THR-11, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- FUNCTION: Functions as a sodium-dependent amino acid transporter.
CC       Mediates the saturable, pH-sensitive and electrogenic cotransport of
CC       glutamine and sodium ions with a stoichiometry of 1:1. May also
CC       transport small zwitterionic and aliphatic amino acids with a lower
CC       affinity. May supply glutamatergic and GABAergic neurons with glutamine
CC       which is required for the synthesis of the neurotransmitters glutamate
CC       and GABA. {ECO:0000269|PubMed:11325958}.
CC   -!- ACTIVITY REGULATION: Inhibited by lithium, potassium, choline ions, N-
CC       methyl-D-glucamine and 2-methylamino-isobutyric acid (MeAIB).
CC       {ECO:0000250}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=2400 uM for L-glutamine (at pH 7.0) {ECO:0000269|PubMed:11325958};
CC         KM=890 uM for L-glutamine (at pH 7.5) {ECO:0000269|PubMed:11325958};
CC         KM=540 uM for L-glutamine (at pH 8.0) {ECO:0000269|PubMed:11325958};
CC         Note=Decrease in pH from 8.0 to 7.0 results in decreased affinity for
CC         L-glutamine.;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass membrane
CC       protein {ECO:0000250}. Note=Restricted to the somatodendritic
CC       compartment of neurons. Found in the cellular processes of neurons in
CC       the developing brain. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8K2P7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8K2P7-2; Sequence=VSP_029307, VSP_029308;
CC       Name=3;
CC         IsoId=Q8K2P7-3; Sequence=VSP_029305, VSP_029306;
CC   -!- TISSUE SPECIFICITY: Specifically expressed in brain and retina (at
CC       protein level). Also detected in spleen, small intestine and lung.
CC       {ECO:0000269|PubMed:11325958}.
CC   -!- INDUCTION: Up-regulated by BDNF. {ECO:0000269|PubMed:17179157}.
CC   -!- SIMILARITY: Belongs to the amino acid/polyamine transporter 2 family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF184240; AAG43433.2; -; mRNA.
DR   EMBL; AK029189; BAC26341.1; -; mRNA.
DR   EMBL; AK034130; BAC28597.1; -; mRNA.
DR   EMBL; AK035098; BAC28944.1; -; mRNA.
DR   EMBL; AK047459; BAC33064.1; -; mRNA.
DR   EMBL; AK049294; BAC33663.1; -; mRNA.
DR   EMBL; AK050914; BAC34457.1; -; mRNA.
DR   EMBL; AK081724; BAC38310.1; -; mRNA.
DR   EMBL; AK162612; BAE36989.1; -; mRNA.
DR   EMBL; AK163914; BAE37532.1; -; mRNA.
DR   EMBL; AK165188; BAE38067.1; -; mRNA.
DR   EMBL; BC030378; AAH30378.1; -; mRNA.
DR   EMBL; BC066815; AAH66815.1; -; mRNA.
DR   CCDS; CCDS27777.1; -. [Q8K2P7-1]
DR   RefSeq; NP_001159928.1; NM_001166456.1. [Q8K2P7-1]
DR   RefSeq; NP_001159930.1; NM_001166458.1. [Q8K2P7-1]
DR   RefSeq; NP_598847.2; NM_134086.4. [Q8K2P7-1]
DR   RefSeq; XP_006520298.1; XM_006520235.3. [Q8K2P7-1]
DR   AlphaFoldDB; Q8K2P7; -.
DR   SMR; Q8K2P7; -.
DR   BioGRID; 222905; 1.
DR   STRING; 10090.ENSMUSP00000097833; -.
DR   GlyGen; Q8K2P7; 2 sites.
DR   iPTMnet; Q8K2P7; -.
DR   PhosphoSitePlus; Q8K2P7; -.
DR   SwissPalm; Q8K2P7; -.
DR   EPD; Q8K2P7; -.
DR   MaxQB; Q8K2P7; -.
DR   PaxDb; Q8K2P7; -.
DR   PeptideAtlas; Q8K2P7; -.
DR   PRIDE; Q8K2P7; -.
DR   ProteomicsDB; 256568; -. [Q8K2P7-1]
DR   ProteomicsDB; 256569; -. [Q8K2P7-2]
DR   ProteomicsDB; 256570; -. [Q8K2P7-3]
DR   ABCD; Q8K2P7; 2 sequenced antibodies.
DR   Antibodypedia; 7400; 199 antibodies from 29 providers.
DR   DNASU; 105727; -.
DR   Ensembl; ENSMUST00000088452; ENSMUSP00000085799; ENSMUSG00000023169. [Q8K2P7-1]
DR   Ensembl; ENSMUST00000088454; ENSMUSP00000085801; ENSMUSG00000023169. [Q8K2P7-1]
DR   Ensembl; ENSMUST00000100262; ENSMUSP00000097833; ENSMUSG00000023169. [Q8K2P7-1]
DR   Ensembl; ENSMUST00000230767; ENSMUSP00000155160; ENSMUSG00000023169. [Q8K2P7-3]
DR   GeneID; 105727; -.
DR   KEGG; mmu:105727; -.
DR   UCSC; uc007xkh.2; mouse. [Q8K2P7-1]
DR   UCSC; uc007xkk.2; mouse. [Q8K2P7-2]
DR   UCSC; uc007xkl.2; mouse. [Q8K2P7-3]
DR   CTD; 81539; -.
DR   MGI; MGI:2145895; Slc38a1.
DR   VEuPathDB; HostDB:ENSMUSG00000023169; -.
DR   eggNOG; KOG1305; Eukaryota.
DR   GeneTree; ENSGT00940000160716; -.
DR   HOGENOM; CLU_009020_0_2_1; -.
DR   InParanoid; Q8K2P7; -.
DR   OMA; LTQRIWA; -.
DR   OrthoDB; 697331at2759; -.
DR   PhylomeDB; Q8K2P7; -.
DR   TreeFam; TF328787; -.
DR   Reactome; R-MMU-210455; Astrocytic Glutamate-Glutamine Uptake And Metabolism.
DR   Reactome; R-MMU-352230; Amino acid transport across the plasma membrane.
DR   BioGRID-ORCS; 105727; 1 hit in 76 CRISPR screens.
DR   ChiTaRS; Slc38a1; mouse.
DR   PRO; PR:Q8K2P7; -.
DR   Proteomes; UP000000589; Chromosome 15.
DR   RNAct; Q8K2P7; protein.
DR   Bgee; ENSMUSG00000023169; Expressed in placenta labyrinth and 252 other tissues.
DR   Genevisible; Q8K2P7; MM.
DR   GO; GO:0030424; C:axon; IDA:MGI.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:ARUK-UCL.
DR   GO; GO:0098591; C:external side of apical plasma membrane; ISO:MGI.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; IDA:MGI.
DR   GO; GO:0043025; C:neuronal cell body; ISO:MGI.
DR   GO; GO:0005886; C:plasma membrane; IDA:MGI.
DR   GO; GO:0015179; F:L-amino acid transmembrane transporter activity; ISO:MGI.
DR   GO; GO:0015186; F:L-glutamine transmembrane transporter activity; IDA:MGI.
DR   GO; GO:0005295; F:neutral amino acid:sodium symporter activity; ISO:MGI.
DR   GO; GO:0003333; P:amino acid transmembrane transport; IBA:GO_Central.
DR   GO; GO:0007565; P:female pregnancy; IEA:Ensembl.
DR   GO; GO:0006868; P:glutamine transport; IDA:MGI.
DR   GO; GO:1902475; P:L-alpha-amino acid transmembrane transport; ISO:MGI.
DR   GO; GO:0015804; P:neutral amino acid transport; ISO:MGI.
DR   InterPro; IPR013057; AA_transpt_TM.
DR   Pfam; PF01490; Aa_trans; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Amino-acid transport; Cell membrane; Disulfide bond;
KW   Glycoprotein; Ion transport; Membrane; Phosphoprotein; Reference proteome;
KW   Sodium; Sodium transport; Symport; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN           1..485
FT                   /note="Sodium-coupled neutral amino acid transporter 1"
FT                   /id="PRO_0000310476"
FT   TOPO_DOM        1..74
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        75..97
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        98..112
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        113..133
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        134..148
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        149..169
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        170..188
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        189..211
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        212..216
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        217..237
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        238..273
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        274..294
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        295..310
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        311..331
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        332..348
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        349..369
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        370..391
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        392..412
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        413..414
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        415..435
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        436..450
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        451..471
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        472..485
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         6
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         11
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         25
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H2H9"
FT   MOD_RES         28
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H2H9"
FT   MOD_RES         49
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H2H9"
FT   MOD_RES         52
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H2H9"
FT   MOD_RES         54
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H2H9"
FT   MOD_RES         56
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H2H9"
FT   CARBOHYD        251
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        257
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        245..262
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   VAR_SEQ         67..72
FT                   /note="IPGTTS -> VSIICM (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_029305"
FT   VAR_SEQ         73..485
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_029306"
FT   VAR_SEQ         333..344
FT                   /note="EKVQSDLLHKYQ -> GKLLPLAMPICT (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_029307"
FT   VAR_SEQ         345..485
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_029308"
FT   CONFLICT        48
FT                   /note="E -> G (in Ref. 2; BAE38067)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        244
FT                   /note="P -> H (in Ref. 2; BAC33064)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        354
FT                   /note="V -> A (in Ref. 1; AAG43433)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        360
FT                   /note="V -> A (in Ref. 1; AAG43433)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   485 AA;  53795 MW;  1171E1458818977C CRC64;
     MMHFKSGLEL TELQNMTVPE DDNVSNDSND FTEVENGQIN SKFISDRESR RSLTNSHLEK
     RKCDEYIPGT TSLGMSVFNL SNAIMGSGIL GLAFALANTG ILLFLILLTS VTLLSIYSIN
     LLLICSKETG CMVYEKLGEQ VFGTTGKLVI FGATSLQNTG AMLSYLFIVK NELPSAIKSL
     MGEEDAFSAW YVDGRVLVVM VTFGIILPLC LLKNLGYLGY TSGFSLSCMM FFLIVVIYKK
     FQTPCMSVEQ NSTVSANVTD ACTPKYVTFN SKTVYALPTI AFAFVCHPSV LPIYSELKDR
     SQKKMQMVSN ISFFAMFVMY FLTAIFGYLT FYEKVQSDLL HKYQSTGDIL ILTVRLAVIV
     AVILTVPVLF FTVRSSLFEL AKKTKFHLCR HVLVTIILLI IINLLVIFIP SMKDIFGVVG
     VTSANMLIFI LPSSLYLKIT NQDGDKGTQR IWAALFLGLG VLFSLISIPL VIYDWACSSG
     TDEGH
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024